BioStem Technologies, Inc.

BioStem Technologies, Inc.verified

BSEM

Price:

$3.999

Market Cap:

$66.65M

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The c...[Read more]

Industry

Biotechnology

IPO Date

2015-03-17

Stock Exchange

OTC

Ticker

BSEM

The Enterprise Value as of December 2025 (TTM) for BioStem Technologies, Inc. (BSEM) is 39.39M

According to BioStem Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.39M. This represents a change of -79.07% compared to the average of 188.23M of the last 4 quarters.

BioStem Technologies, Inc. (BSEM) Historical Enterprise Value (quarterly & annually)

How has BSEM Enterprise Value performed in the past?

The mean historical Enterprise Value of BioStem Technologies, Inc. over the last ten years is 54.02M. The current 39.39M Enterprise Value has changed 7.19% with respect to the historical average. Over the past ten years (40 quarters), BSEM's Enterprise Value was at its highest in in the March 2024 quarter at 256.62M. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

54.02M

Median

32.07M

Minimum

16.64M

Maximum

208.10M

BioStem Technologies, Inc. (BSEM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioStem Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 356.33%

Maximum Annual Enterprise Value = 208.10M

Minimum Annual Increase = -53.41%

Minimum Annual Enterprise Value = 16.64M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024208.10M145.23%
202384.86M120.19%
202238.54M131.55%
202116.64M-11.62%
202018.83M-32.99%
201928.10M-6.21%
201829.97M-53.41%
201764.31M88.18%
201634.18M105.01%
201516.67M356.33%

BioStem Technologies, Inc. (BSEM) Average Enterprise Value

How has BSEM Enterprise Value performed in the past?

The current Enterprise Value of BioStem Technologies, Inc. (BSEM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

110.50M

5-year avg

73.39M

10-year avg

54.02M

BioStem Technologies, Inc. (BSEM) Enterprise Value vs. Peers

How is BSEM’s Enterprise Value compared to its peers?

BioStem Technologies, Inc.’s Enterprise Value is greater than IXICO plc (5.88M), greater than Nicox S.A. (31.80M), less than Alterity Therapeutics Limited (48.31M), less than Satellos Bioscience Inc. (41.10M), less than Calliditas Therapeutics AB (publ) (11.24B), less than Actinogen Medical Limited (168.15M), greater than MedX Health Corp (23.56M), less than Imugene Limited (81.08M), greater than ZIVO Bioscience, Inc. (38.87M), less than Vicapsys Life Sciences, Inc. (49.13M),

Build a custom stock screener for BioStem Technologies, Inc. (BSEM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioStem Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioStem Technologies, Inc. (BSEM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioStem Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioStem Technologies, Inc.'s Enterprise Value?

What is the highest Enterprise Value for BioStem Technologies, Inc. (BSEM)?

What is the 3-year average Enterprise Value for BioStem Technologies, Inc. (BSEM)?

What is the 5-year average Enterprise Value for BioStem Technologies, Inc. (BSEM)?

How does the current Enterprise Value for BioStem Technologies, Inc. (BSEM) compare to its historical average?